Barton Shane

Principal Accounting OfficerBioAge Labs, Inc. (BIOA) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
18
10 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Option exercise(M)4K$10.85$47K4K
Jun 30, 2026Option exercise(M)4K$8.39$34K8K
Jun 30, 2026Option exercise(M)4K$4.30$17K12K
Jun 30, 2026Option exercise(M)8K$4.38$34K20K
Jun 30, 2026Sell(S)20K$25.19$509K0
Jun 29, 2026Option exercise(M)9K$10.85$101K12K
Jun 29, 2026Option exercise(M)7K$8.39$61K19K
Jun 29, 2026Option exercise(M)9K$4.30$39K28K
Jun 29, 2026Option exercise(M)14K$4.38$62K42K
Jun 29, 2026Sell(S)42K$25.21$1.1M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2026Option exercise(M)8K$068K
Jun 30, 2026Option exercise(M)4K$013K
Jun 30, 2026Option exercise(M)4K$017K
Jun 30, 2026Option exercise(M)4K$027K
Jun 29, 2026Option exercise(M)9K$018K
Jun 29, 2026Option exercise(M)7K$021K
Jun 29, 2026Option exercise(M)9K$031K
Jun 29, 2026Option exercise(M)14K$076K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001836297-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly: